Cargando…

The Role of Growth Hormone and Insulin Growth Factor 1 in the Development of Non-Alcoholic Steato-Hepatitis: A Systematic Review

Diabetic and obese patients have a high prevalence of non-alcoholic fatty liver disease (NAFLD). This condition groups a spectrum of conditions varying from simple steatosis to non-alcoholic steatohepatitis (NASH), with or without fibrosis. Multiple factors are involved in the development of NAFLD....

Descripción completa

Detalles Bibliográficos
Autores principales:	Cristin, Luca, Montini, Amalia, Martinino, Alessandro, Scarano Pereira, Juan Pablo, Giovinazzo, Francesco, Agnes, Salvatore
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Systematic Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9954460/ https://www.ncbi.nlm.nih.gov/pubmed/36831184 http://dx.doi.org/10.3390/cells12040517

Ejemplares similares

Artificial Intelligence in the Diagnosis of Hepatocellular Carcinoma: A Systematic Review
por: Martinino, Alessandro, et al.
Publicado: (2022)

The Role of mTOR Inhibitors after Liver Transplantation for Hepatocellular Carcinoma
por: Todeschini, Letizia, et al.
Publicado: (2023)

Lifestyle interventions for patients with non-alcoholic steato-hepatitis–Design, rationale and protocol of the study “target group-specific optimisation of lifestyle interventions for behavior change in non-alcoholic steato-hepatitis (OPTI-NASH)”
por: Krüger, Kathrin, et al.
Publicado: (2023)

HEPATITIS VIRUS C INFECTION, ADIPOKINES AND HEPATIC STEATO–FIBROSIS
por: Ciurtin, C, et al.
Publicado: (2008)

A New SteatoScore in the Evaluation of Non-Alcoholic Liver Disease in Oncologic Patients
por: Cioni, Dania, et al.
Publicado: (2022)

Supplementation with crude rhubarb extract lessens liver inflammation and hepatic lipid accumulation in a model of acute alcohol-induced steato-hepatitis
por: Neyrinck, Audrey M, et al.
Publicado: (2014)

Diagnostic value of biochemical markers (NashTest) for the prediction of non alcoholo steato hepatitis in patients with non-alcoholic fatty liver disease
por: Poynard, Thierry, et al.
Publicado: (2006)

The diagnostic value of biomarkers (SteatoTest) for the prediction of liver steatosis
por: Poynard, Thierry, et al.
Publicado: (2005)

Foetal programming by methyl donor deficiency produces steato-hepatitis in rats exposed to high fat diet
por: Bison, Anaïs, et al.
Publicado: (2016)

Performance of liver biomarkers, in patients at risk of nonalcoholic steato-hepatitis, according to presence of type-2 diabetes
por: Poynard, Thierry, et al.
Publicado: (2019)

The Role of PTEN in Chronic Growth Hormone-Induced Hepatic Insulin Resistance
por: Gao, Yuan, et al.
Publicado: (2013)

The diagnostic performance of a simplified blood test (SteatoTest-2) for the prediction of liver steatosis
por: Poynard, Thierry, et al.
Publicado: (2019)

Growth hormone and insulin-like growth factor 1 affect the severity of Graves’ disease
por: Di Cerbo, Alfredo, et al.
Publicado: (2017)

Prognostic Factors in Patients with Breast Cancer Liver Metastases Undergoing Liver Resection: Systematic Review and Meta-Analysis
por: Galiandro, Federica, et al.
Publicado: (2022)

Prognostic Models in Growth-Hormone- and Prolactin-Secreting Pituitary Neuroendocrine Tumors: A Systematic Review
por: Dumitriu-Stan, Roxana-Ioana, et al.
Publicado: (2023)

Efficacy and safety of endoscopic sleeve gastroplasty versus laparoscopic sleeve gastrectomy in obese subjects with Non-Alcoholic SteatoHepatitis (NASH): study protocol for a randomized controlled trial (TESLA-NASH study)
por: Lavín-Alconero, Lucía, et al.
Publicado: (2021)

SteatoNet: The First Integrated Human Metabolic Model with Multi-layered Regulation to Investigate Liver-Associated Pathologies
por: Naik, Adviti, et al.
Publicado: (2014)

Diagnostic performance of FibroTest, SteatoTest and ActiTest in patients with NAFLD using the SAF score as histological reference
por: Munteanu, M., et al.
Publicado: (2016)

The Role of Growth Hormone and Insulin-Like Growth Factor-I in the Liver
por: Takahashi, Yutaka
Publicado: (2017)

Growth Hormone and Insulin-Like Growth Factor Action in Reproductive Tissues
por: Ipsa, Emina, et al.
Publicado: (2019)

Carnitine palmitoyl transferase 1A deficiency in an adult with recurrent severe steato hepatitis aggravated by high pathologic or physiologic demands: A roller-coaster for internists
por: Phowthongkum, Prasit, et al.
Publicado: (2019)

Multiple Effects of Growth Hormone in the Body: Is it Really the Hormone for Growth?
por: Devesa, Jesús, et al.
Publicado: (2016)

The growth hormone–insulin-like growth factor-I axis in the diagnosis and treatment of growth disorders
por: Blum, Werner F, et al.
Publicado: (2018)

PSUN314 Severe Insulin Resistance Impacts the Growth Hormone-Insulin-Like Growth Factor-I Axis and Linear Growth
por: Okawa, Marinna
Publicado: (2022)

The Role of the Growth Hormone/Insulin-Like Growth Factor System in Visceral Adiposity
por: Lewitt, Moira S
Publicado: (2017)

Delirium, insulin-like growth factor I, growth hormone in older inpatients
por: Adamis, Dimitrios, et al.
Publicado: (2020)

Chronic inflammation and the growth hormone/insulin-like growth factor-1 axis
por: Witkowska-Sędek, Ewelina, et al.
Publicado: (2021)

Growth in Children With Noonan Syndrome and Effects of Growth Hormone Treatment on Adult Height
por: Libraro, Annachiara, et al.
Publicado: (2021)

THU047 Growth Hormone (GH) Signaling In Hepatocytes Controls Hepatic Insulin Sensitivity And Nutrient Disposition
por: del Rio-Moreno, Mercedes, et al.
Publicado: (2023)

Growth Hormone Control of Hepatic Lipid Metabolism
por: Liu, Zhongbo, et al.
Publicado: (2016)

Insulin sensitivity in long-lived growth hormone-releasing hormone knockout mice
por: Zhang, Fang, et al.
Publicado: (2020)

Effect of Growth Hormone and Estrogen Replacement Therapy on Bone Mineral Density in Women with Turner Syndrome: A Meta-Analysis and Systematic Review
por: Szybiak, Weronika, et al.
Publicado: (2023)

Growth Axis Somatostatin, Growth Hormone Receptor, and Insulin-like Growth Factor-1 Genes Express and Are Affected by the Injection of Exogenous Growth Hormone in Chinemys reevesii
por: Xie, Rui-Lin, et al.
Publicado: (2023)

Treatment of Pre-pubertal Patients with Growth Hormone Deficiency: Patterns in Growth Hormone Dosage and Insulin-like Growth Factor-I Z-scores
por: Oberle, Megan, et al.
Publicado: (2017)

Growth hormone, insulin-like growth factor 1, and insulin signaling—a pharmacological target in body wasting and cachexia
por: Trobec, Katja, et al.
Publicado: (2011)

Relationship among Insulin Resistance, Growth Hormone, and Insulin‐Like Growth Factor I Concentrations in Diestrous Swedish Elkhounds
por: Strage, E.M., et al.
Publicado: (2014)

Growth and growth hormone - Insulin Like Growth Factor - I (GH-IGF-I) axis in chronic anemias
por: Ashraf, T. Soliman, et al.
Publicado: (2017)

Growth Hormone(s), Testosterone, Insulin-Like Growth Factors, and Cortisol: Roles and Integration for Cellular Development and Growth With Exercise
por: Kraemer, William J., et al.
Publicado: (2020)

Effects of gender-affirming hormone therapy on insulin resistance and body composition in transgender individuals: A systematic review
por: Spanos, Cassandra, et al.
Publicado: (2020)

Adult growth hormone deficiency treatment with a combination of growth hormone and insulin-like growth factor-1 resulting in elevated sustainable insulin-like growth factor-1 and insulin-like growth factor binding protein 3 plasma levels: a case report
por: Braverman, Eric R, et al.
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_lbul6atlpb4odd7p0ie8idpvkm